Gliclazide
"Gliclazide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
Descriptor ID |
D005907
|
MeSH Number(s) |
D02.886.590.795.475 D02.948.828.475
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Gliclazide".
Below are MeSH descriptors whose meaning is more specific than "Gliclazide".
This graph shows the total number of publications written about "Gliclazide" by people in this website by year, and whether "Gliclazide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gliclazide" by people in Profiles.
-
Jarrard RE, Wang Y, Salyer AE, Pratt EP, Soderling IM, Guerra ML, Lange AM, Broderick HJ, Hockerman GH. Potentiation of sulfonylurea action by an EPAC-selective cAMP analog in INS-1 cells: comparison of tolbutamide and gliclazide and a potential role for EPAC activation of a 2-APB-sensitive Ca2+ influx. Mol Pharmacol. 2013 Jan; 83(1):191-205.
-
Del Guerra S, Grupillo M, Masini M, Lupi R, Bugliani M, Torri S, Boggi U, Del Chiaro M, Vistoli F, Mosca F, Del Prato S, Marchetti P. Gliclazide protects human islet beta-cells from apoptosis induced by intermittent high glucose. Diabetes Metab Res Rev. 2007 Mar; 23(3):234-8.